OtoNexus Medical Technologies, Inc.
OtoNexus Medical Technologies is dedicated to revolutionizing the diagnosis and management of middle ear infections (Otitis Media) through innovative ultrasound technology. Their portable, lightweight ultrasound otoscope provides instant, accurate, and objective diagnostics, helping clinicians determine the presence and type of infection within seconds. The company's mission is to improve patient care, reduce unnecessary antibiotic use, and lower healthcare costs by providing a reliable, non-invasive diagnostic tool that supports antibiotic stewardship and aligns with public health guidelines. With a strong leadership team, extensive patent portfolio, and recognition from regulatory and industry programs, OtoNexus aims to set a new standard in pediatric healthcare diagnostics and expand its technology platform for broader medical and industrial applications.
Industries
Nr. of Employees
small (1-50)
OtoNexus Medical Technologies, Inc.
Patents
Apparatus and method for characterization of a ductile membrane, surface and sub-surface properties
US-12167936-B2
View DetailsSmall scale, capacitive ultrasound transducer devices with improved directionality and methods for their use
US-12156764-B2
View DetailsMethods and devices for membrane characterization with ultrasound and optical illumination
US-12156765-B2
View DetailsMethods and devices for membrane characterization with ultrasound and optical illumination
US-12076186-B2
View Details
Apparatus and method for characterization of a ductile membrane, surface and sub-surface properties
US-12167936-B2
View DetailsSmall scale, capacitive ultrasound transducer devices with improved directionality and methods for their use
US-12156764-B2
View DetailsMethods and devices for membrane characterization with ultrasound and optical illumination
US-12156765-B2
View DetailsMethods and devices for membrane characterization with ultrasound and optical illumination
US-12076186-B2
View DetailsProducts
Ultrasound otoscope for middle-ear infection detection
A portable handheld otoscope incorporating a miniaturized through-air ultrasound transducer and onboard signal analysis to provide immediate diagnostic data on presence and type of middle-ear effusion.
Ultrasound otoscope for middle-ear infection detection
A portable handheld otoscope incorporating a miniaturized through-air ultrasound transducer and onboard signal analysis to provide immediate diagnostic data on presence and type of middle-ear effusion.
Services
Partnerships with pediatric hospitals and academic centers to conduct clinical validation studies, surgical correlation studies, and microbiota analyses to support product claims.
Regulatory strategy support including preparation for accelerated FDA engagement and pathways (e.g., programs that expedite review), and experience navigating device submissions and quality system requirements.
Commercial strategy and investor engagement focusing on capital device distribution paired with recurring consumable sales and channel development.
Partnerships with pediatric hospitals and academic centers to conduct clinical validation studies, surgical correlation studies, and microbiota analyses to support product claims.
Regulatory strategy support including preparation for accelerated FDA engagement and pathways (e.g., programs that expedite review), and experience navigating device submissions and quality system requirements.
Commercial strategy and investor engagement focusing on capital device distribution paired with recurring consumable sales and channel development.
Expertise Areas
- Point-of-care ultrasound diagnostics
- Clinical study design and execution
- Medical device commercialization
- Regulatory strategy for medical devices (FDA, CE)
Key Technologies
- Through-air ultrasound
- Miniaturized ultrasound transducers
- Ultrasound signal processing
- Algorithmic classification of diagnostic signals
News & Updates
The FDA Safer Technologies Program (STeP) fast-tracks innovative medical devices that significantly improve patient care and safety. OtoNexus was selected for this program in December 2023, validating its technology and accelerating its path to market.
OtoNexus was recognized as the Most Valued Company at the Keiretsu Forum Investor Capital Expo 2024, highlighting its innovative contributions to pediatric healthcare diagnostics.
In July 2022, OtoNexus was honored as a Top Infection Control Solution Provider by MedTech Outlook, recognizing its impact on infection control and antimicrobial stewardship.
In June 2021, OtoNexus was selected for the MedTech Innovator Accelerator and Showcase Program, a prestigious initiative supporting innovative medical device startups.
Industry awards and recognition from various organizations highlight OtoNexus's leadership and innovation in pediatric ear infection diagnostics.
OtoNexus's breakthrough ultrasound otoscope offers a new standard for diagnosing middle ear infections quickly and accurately, reducing unnecessary antibiotic use.
The FDA Safer Technologies Program (STeP) fast-tracks innovative medical devices that significantly improve patient care and safety. OtoNexus was selected for this program in December 2023, validating its technology and accelerating its path to market.
OtoNexus was recognized as the Most Valued Company at the Keiretsu Forum Investor Capital Expo 2024, highlighting its innovative contributions to pediatric healthcare diagnostics.
In July 2022, OtoNexus was honored as a Top Infection Control Solution Provider by MedTech Outlook, recognizing its impact on infection control and antimicrobial stewardship.
In June 2021, OtoNexus was selected for the MedTech Innovator Accelerator and Showcase Program, a prestigious initiative supporting innovative medical device startups.
Industry awards and recognition from various organizations highlight OtoNexus's leadership and innovation in pediatric ear infection diagnostics.
OtoNexus's breakthrough ultrasound otoscope offers a new standard for diagnosing middle ear infections quickly and accurately, reducing unnecessary antibiotic use.